Paediatric heart failure trials...and tribulations

Cardiology in the Young

Volumn 17, Issue 4, 2007, Pages 354-355

  Shaddy, Robert E ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac failure; Children; Endpoints

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BISOPROLOL; BRAIN NATRIURETIC PEPTIDE; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO;

CHILDHOOD DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DRUG EFFICACY; EDITORIAL; EXERCISE; FALLOT TETRALOGY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE OXYGEN CONSUMPTION; HEART SURGERY; HUMAN; MORTALITY; OUTCOME ASSESSMENT; PEDIATRIC SURGERY; PHYSICAL CAPACITY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RISK REDUCTION; SYMPTOMATOLOGY;

ADRENERGIC BETA-ANTAGONISTS; BISOPROLOL; CHILD; EXERCISE TOLERANCE; HEART FAILURE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RESEARCH DESIGN; TETRALOGY OF FALLOT; TREATMENT OUTCOME;

EID: 34547686489     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951107000790     Document Type: Editorial

References (10)

1. Norozi K, Bahlmann J, Raab B, et al. A prospective, randomized, double-blind, placebo controlled trial of beta-blockade in patients who have undergone surgical correction of tetralogy of Fallot. Cardiol Young 2007; 17: Current issue...
2. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial. Lancet 1999; 353: 9-13.
3. Bristow MR, Gilbert EM, Abraham WT, et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation 1996; 94: 2807-2816.
4. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999; 353: 2001-2007.
5. Packer M, Fowler MB, Roecker EB, et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: Results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 2002; 106: 2194-2199.
6. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group [see comments]. N Engl J Med 1996; 334: 1349-1355.
7. Kouatli AA, Garcia JA, Zellers TM, Weinstein EM, Mahony L. Enalapril does not enhance exercise capacity in patients after Fontan procedure. Circulation 1997; 96: 1507-1512.
8. Hechter SJ, Fredriksen PM, Liu P, et al. Angiotensin-converting enzyme inhibitors in adults after the Mustard procedure. Am J Cardiol 2001; 87: 660-663, A11.
9. Dore A, Houde C, Chan KL, et al. Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: A multicenter, randomized, placebo-controlled clinical trial. Circulation 2005; 112: 2411-2416.
10. Small Clinical Trials: Issues and Challenges. Institute of Medicine, 2001. (Accessed at http://www.iom.edu/report.asp?id=5483).